Results 211 to 220 of about 12,043,843 (293)

Arterial hypertension: interrelation between heart, arterial and venous structure and function, their prognostic role in antihypertensive treatment optimization

, 2008
А В Туев, О. В. Хлынова, В. В. Щекотов, А. В. Агафонов   +3 more
openalex   +1 more source

Benefits and harms of antihypertensive treatment for low risk mild hypertension: a real world, matched cohort study of over 38,000 adults

, 2018
James P Sheppard, Sarah Stevens, Richard Stevens, Una Martin, M Jonathan, Richard Hobbs, Richard J. McManus   +6 more
openalex   +1 more source

Deviation From Genetically Predicted BMI and All‐Cause Mortality: A Cohort Study in the UK Biobank

Obesity, EarlyView.
ABSTRACT Objective The relation between genetically predicted BMI (gBMI) and actual BMI may have health effects. This study examines the relationship between deviations from gBMI and all‐cause mortality in 208,146 UK Biobank participants. Methods We derived gBMI from polygenic risk scores, with deviations calculated as the difference between observed ...
Nuno R. Zilhao, Jie Zhang, Dorret I. Boomsma, Thorkild I. A. Sørensen, Christina C. Dahm   +4 more
wiley   +1 more source

Antihypertensive Treatment Patterns in CKD Stages 3 and 4: The CKD-REIN Cohort Study. [PDF]

Kidney Med
Costes-Albrespic M, Liabeuf S, Laville S, Jacquelinet C, Combe C, Fouque D, Laville M, Frimat L, Pecoits-Filho R, Lambert O, Massy ZA, Sautenet B, Alencar de Pinho N, CKD-REIN study group.   +13 more
europepmc   +1 more source

Risk of dementia in patients taking beta blocker as antihypertensive treatment: a cross sectional study

, 2019
Mervin K. Soman, Sankara Thiagarajan, S. Priyanka, V. Subashini   +3 more
openalex   +2 more sources

Withdrawing antihypertensive treatment: Authors' reply [PDF]

, 1991
M Aylett, S Ketchin
openalex   +1 more source

Long‐term remission in gout: Challenges and future opportunities

Rheumatology &Autoimmunity, EarlyView.
Prolonged hyperuricemia is a major risk factor for gout, which is now regarded as a curable disease. Awareness of the various factors that can trigger gout flares is essential for their prevention. An important determinant of treatment decisions and long‐term follow‐up is the quality of the clinician–patient relationship. The “treat‐to‐target” approach
Patapong Towiwat, Zhanguo Li
wiley   +1 more source

Complex Patterns of Antihypertensive Treatment Changes in Long-Term Care Residents. [PDF]

J Am Med Dir Assoc
Liu X, Jing B, Graham LA, Liu CK, Lee SJ, Steinman MA, Dave CV, Manja V, Li Y, Fung K, Odden MC.   +10 more
europepmc   +1 more source

Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial.

BMJ, 2023
Liu L, Xie X, Pan Y, Wang A, Wei Y, Liu J, Nie X, Liu D, Zhao Z, Wang P, Shen S, Zhong C, Xu T, Wang D, Wang GC, Song D, Ma Y, Zhao J, Jiang Y, Jing J, Meng X, Obst K, Chen CS, Wang D, Wang Y, Zhang Y, Wang Y, He J, CATIS-2 Investigators.   +28 more
europepmc   +1 more source

Hepatic fibrosis in patients diagnosed with rheumatoid arthritis and psoriatic arthritis receiving methotrexate: A cross‐sectional analysis using transient elastography

Rheumatology &Autoimmunity, EarlyView.
Hepatic fibrosis and metabolic syndrome are more prevalent in PsA patients treated with methotrexate, compared to RA patients. Metabolic syndrome is associated with the risk of hepatic fibrosis in patients diagnosed with PsA and RA even after adjustment forcumulative methotrexate exposure.
Ratchaya Lertnawapan, Soonthorn Chonprasertsuk, Sith Siramolpiwat, Kanon Jatuworapruk   +3 more
wiley   +1 more source